肝微波消融后凝固性坏死早期评估:非增强与增强T1加权成像的比较
回顾性研究纳入56例肝恶性肿瘤患者(56个病灶)行经皮微波消融,消融后2天内行非增强与增强T1加权成像,比较两种方法评估消融效果及局部肿瘤进展(LTP)。非增强T1加权图像上消融区呈特征性「高信号中带+周围低信号带」双带结构,有助于早期判断消融是否完全。
要点
- 非增强T1加权图像上消融区呈「高信号中带+周围低信号带」双带结构,为凝固性坏死的特征表现。
- 非增强T1加权图像判断消融不全的病例中,部分在门静脉期图像上显示为完全消融。
- 非增强T1加权图像可用于微波消融后早期评估疗效。
核心结论
- 非增强T1加权成像有助于肝肿瘤微波消融术后早期评估治疗效果。
研究设计与样本
- 回顾性研究,2014年9月至2015年12月间纳入56例患者共56个肝脏恶性病灶,行经皮微波消融,消融后2天内行非增强与增强T1加权成像,以随访≥7个月期间出现局部肿瘤进展为终点。
关键影像表现/征象
- 非增强T1加权图像上消融区呈特征性双带结构,即高信号中带和周围低信号带。
- 56例中10例出现局部肿瘤进展,其中7例的非增强T1加权图像和门静脉期图像均显示肿瘤消融不完全。
- 其余3例中2例非增强T1加权图像显示消融不完全,而相应门静脉期图像显示完全消融;另1例两种图像均未见残留肿瘤。
- 46例无局部肿瘤进展的患者中,消融后早期非增强T1加权图像和门静脉期图像均未见残留肿瘤证据。
诊断标准与关键数值
- 非增强T1加权图像以高信号中带评估消融效果。
- 增强T1加权图像以无增强区域评估消融效果。
临床应用与阅片要点
- 消融后早期可观察非增强T1加权图像上消融区是否呈「高信号中带+周围低信号带」双带结构,以辅助判断凝固性坏死范围。
- 非增强T1加权图像显示消融不全时,需结合门静脉期图像综合判断,因部分病例门静脉期图像可显示完全消融。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the technical success and accuracy of hepatic microwave ablation (MWA) using non-enhanced and enhanced T1-weighted imaging early after ablation. Patients were evaluated with regard to the ablation zone and local tumor progression (LTP).
METHODS: This retrospective study conducted between September 2014 and December 2015 which consisted of 56 patients with 56 hepatic malignant lesions who underwent percutaneous MWA. Non-enhanced and contrast-enhanced T1-weighted imagings were performed within 2 days after tumor ablation. The efficacy of ablation assessed according to the hyperintense middle zone on non-enhanced T1-weighted images and the non-enhanced area on contrast-enhanced T1-weighted images were compared. The development of LTP during ≥7 months of follow-up served as the end point.
RESULTS: On the non-enhanced T1-weighted images, the ablated region had a characteristic two-zone structure featuring a hyperintense middle zone and a surrounding hypointense band. Among the 56 patients, LTP developed in ten including seven lesions, in which both the non-enhanced T1-weighted and portal-phase images showed incomplete tumor ablation. In two of the remaining three patients, incomplete tumor ablation was detected on the non-enhanced T1-weighted images, whereas the corresponding portal-phase images showed complete ablation. In the remaining patient, no residual tumor was detected on either the non-enhanced T1-weighted or the portal-phase images. In the 46 patients without LTP, there was no evidence of residual tumor on the non-enhanced T1-weighted or portal-phase images obtained early after ablation.
CONCLUSIONS: Non-enhanced T1-weighted images are useful in assessing the therapeutic efficacy of MWA of liver tumors early after the procedure.
引用
- Jia ZY, Chen QF, Yang ZQ, et al. Early assessment of coagulation necrosis after hepatic microwave ablation: a comparison of non-enhanced and enhanced T1-weighted images. Abdom Radiol (NY). 2017. PMID: 28180923. doi:10.1007/s00261-017-1064-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。